Online registration for this event is now closed. If you would like to register for this event, please contact Customer Service (800) 892-1400, Option 2.
Assessing Cardiovascular Risk in Women Considering Menopausal Hormone Therapy. This program is part of AACC’s 2014 Clinical Chemistry webinar series.Recent studies have shown that many newly menopausal women have a favorable benefits:risk profile on hormone therapy (HT). The key is to apply risk-stratification strategies and personalization of care to identify appropriate candidates for treatment and to avoid HT in women likely to have adverse events. Attend this webinar and know what recent data are telling us about the relationship between HT and CVD risk and how labs can help clinicians assess CVD risk in women considering HT.